Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 26, 2024
Minimal interference of concizumab with standard clinical coagulation laboratory assays - An in vitro study
Cecilia Augustsson, Karin Strandberg, Marianne Kjalke
European Journal of Haematology
|
May 7, 2014
Turoctocog alfa (NovoEight®)--from design to clinical proof of concept
Mirella Ezban, Knud Vad, Marianne Kjalke
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
December 7, 2019
An overview of turoctocog alfa pegol (N8-GP; ESPEROCT<sup>®</sup> ) assay performance: Implications for postadministration monitoring
Mirella Ezban, Martin Hansen, Marianne Kjalke
Journal of Thrombosis and Haemostasis : JTH
|
April 5, 2021
Thrombin generation potential in the presence of concizumab and rFVIIa, APCC, rFVIII, or rFIX: In vitro and ex vivo analyses
Marianne Kjalke, Mads Kjelgaard-Hansen, Søren Andersen, et al.
The Journal of Extra-Corporeal Technology
|
August 18, 2009
Influence of cardiopulmonary bypass on the interaction of recombinant factor VIIa with activated platelets
Marianne Kjalke, Marx Runge, Rasmus Rojkjaer, et al.
Journal of Thrombosis and Haemostasis : JTH
|
November 13, 2024
Examining downstream effects of concizumab in hemophilia A with a mathematical modeling approach
Kenji Miyazawa, Alan E Mast, Adam R Wufsus, et al.
American Journal of Veterinary Research
|
August 2, 2011
Development of a flow cytometric assay for detection of coated platelets in dogs and evaluation of binding of coated platelets to recombinant human coagulation factor VIIa
Tom Knudsen, Marianne Kjalke, Mikael Tranholm, et al.
Transfusion
|
October 26, 2007
Impairment of the hemostatic potential of platelets during storage as evaluated by flow cytometry, thrombin generation, and thrombelastography under conditions promoting formation of coated platelets
Mette S Svendsen, Rasmus Rojkjaer, Annemarie T Kristensen, et al.
Biological Chemistry
|
October 7, 2009
Coagulation factor XIII variants with altered thrombin activation rates
Mette Dahl Andersen, Marianne Kjalke, Susanne Bang, et al.
British Journal of Haematology
|
October 28, 2008
Differential clot stabilising effects of rFVIIa and rFXIII-A2 in whole blood from thrombocytopenic patients and healthy volunteers
Pär I Johansson, Niels Jacobsen, Dorthe Viuff, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 26, 2024
Minimal interference of concizumab with standard clinical coagulation laboratory assays - An in vitro study
Cecilia Augustsson, Karin Strandberg, Marianne Kjalke
European Journal of Haematology
|
May 7, 2014
Turoctocog alfa (NovoEight®)--from design to clinical proof of concept
Mirella Ezban, Knud Vad, Marianne Kjalke
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
December 7, 2019
An overview of turoctocog alfa pegol (N8-GP; ESPEROCT<sup>®</sup> ) assay performance: Implications for postadministration monitoring
Mirella Ezban, Martin Hansen, Marianne Kjalke
Journal of Thrombosis and Haemostasis : JTH
|
April 5, 2021
Thrombin generation potential in the presence of concizumab and rFVIIa, APCC, rFVIII, or rFIX: In vitro and ex vivo analyses
Marianne Kjalke, Mads Kjelgaard-Hansen, Søren Andersen, et al.
The Journal of Extra-Corporeal Technology
|
August 18, 2009
Influence of cardiopulmonary bypass on the interaction of recombinant factor VIIa with activated platelets
Marianne Kjalke, Marx Runge, Rasmus Rojkjaer, et al.
Journal of Thrombosis and Haemostasis : JTH
|
November 13, 2024
Examining downstream effects of concizumab in hemophilia A with a mathematical modeling approach
Kenji Miyazawa, Alan E Mast, Adam R Wufsus, et al.
American Journal of Veterinary Research
|
August 2, 2011
Development of a flow cytometric assay for detection of coated platelets in dogs and evaluation of binding of coated platelets to recombinant human coagulation factor VIIa
Tom Knudsen, Marianne Kjalke, Mikael Tranholm, et al.
Transfusion
|
October 26, 2007
Impairment of the hemostatic potential of platelets during storage as evaluated by flow cytometry, thrombin generation, and thrombelastography under conditions promoting formation of coated platelets
Mette S Svendsen, Rasmus Rojkjaer, Annemarie T Kristensen, et al.
Biological Chemistry
|
October 7, 2009
Coagulation factor XIII variants with altered thrombin activation rates
Mette Dahl Andersen, Marianne Kjalke, Susanne Bang, et al.
British Journal of Haematology
|
October 28, 2008
Differential clot stabilising effects of rFVIIa and rFXIII-A2 in whole blood from thrombocytopenic patients and healthy volunteers
Pär I Johansson, Niels Jacobsen, Dorthe Viuff, et al.
Page
of 2